Evidence map›Paper›PMID 28879074›Full record

ArticleRespiratory medicine case reports2017

A case report of

Nana Zhang, Depu Wang, Xiaofeng Li, Zhe Yang, Guanjun Zhang, Yili Wang, Chunbao Wang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nana ZhangDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Depu WangDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Xiaofeng LiDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Zhe YangDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Guanjun ZhangDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Yili WangInstitute of Cancer Research, School of Basic Medical Science of Xi'an Jiaotong University, Xi'an, 710061, China.
Chunbao WangDepartment of Pathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although a secondary mutation and the epithelial-to-mesenchymal transition (EMT) are encountered very often in patients received the

Indexed as

EGFR-TKI resistanceEpidermal growth factor receptor tyrosine kinase inhibitorEpithelial-to-mesenchymal transitionSecondary mutation

Identifiers

PMID28879074
PMCPMC5576958
OpenAlexW2747941435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.